Stanley Druckenmiller Procept Bio Robotics Corp Transaction History

Duquesne Family Office LLC

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$29.23 - $44.45 $31.8 Million - $48.4 Million
-1,088,775 Reduced 96.52%
39,266 $1.28 Million
Q1 2022

May 16, 2022
SELL
$16.89 - $35.74 $8.99 Million - $19 Million
-532,394 Reduced 32.06%
1,128,041 $39.5 Million
Q4 2021

Feb 14, 2022
BUY
$24.6 - $46.29 $26.1 Million - $49.1 Million
1,060,435 Added 176.74%
1,660,435 $41.5 Million
Q3 2021

Nov 15, 2021
BUY
$35.91 - $41.94 $21.5 Million - $25.2 Million
600,000 New
600,000 $22.9 Million

Others Institutions Holding PRCT

# of Institutions
267
Shares Held
38M
Call Options Held
262K
Put Options Held
257K
View Full List

About PROCEPT BioRobotics Corp

PRCT Quotes by TradingView
  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.34B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track Stanley Druckenmiller's Portfolio

Track Stanley Druckenmiller Portfolio

Follow Stanley Druckenmiller (Duquesne Family Office LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email